Janney Montgomery Scott’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.71M Sell
159,250
-60
-0% -$671 ﹤0.01% 1592
2026
Q2
$1.75M Buy
159,310
+460
+0.3% +$4.34K ﹤0.01% 1565
2026
Q1
$1.29M Buy
158,850
+117,650
+286% +$1.01M ﹤0.01% 1659
2025
Q4
$428K Buy
41,200
+9,850
+31% +$103K ﹤0.01% 2307
2025
Q3
$277K Buy
+31,350
New +$223K ﹤0.01% 2543

Other funds holding KURA

Janney Montgomery Scott's KURA Position: Q3 2026 in Review

Janney Montgomery Scott reduced its Kura Oncology (KURA) stake by 0.04% in Q3 2026, selling an estimated $671 and leaving 159,250 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

Janney Montgomery Scott first reported a position in KURA in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.75M in Q2 2026. 233 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Janney Montgomery Scott held 159,250 shares of Kura Oncology worth $1.71M as of Q3 2026.
  • Janney Montgomery Scott sold 60 Kura Oncology shares in Q3 2026, an estimated $671.
  • Kura Oncology made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q3 2026, its #1592 holding.
  • Janney Montgomery Scott first reported a position in Kura Oncology in Q3 2025 and has held it in 5 quarters since.
  • Janney Montgomery Scott's Kura Oncology position peaked at $1.75M in Q2 2026.
  • 233 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Janney Montgomery Scott's 13F filing for Q3 2026, filed 12 Nov 2026.